Key Insights

Highlights

Success Rate

75% trial completion

Treatment Research

3 treatments under study, led by Azithromycin

Research Leaders

20 sponsors active, led by University of Alabama at Birmingham

Related Conditions

Often studied with 13 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 42/100

Termination Rate

25.0%

1 terminated out of 4 trials

Success Rate

75.0%

-11.6% vs benchmark

Late-Stage Pipeline

50%

2 trials in Phase 3/4

Results Transparency

67%

2 of 3 completed with results

Key Signals

2 with results75% success

Data Visualizations

Phase Distribution

4Total
Not Applicable (2)
Phase 3 (1)
Phase 4 (1)

Trial Status

Completed3
Terminated1

Trial Success Rate

75.0%

Benchmark: 86.6%

Based on 3 completed trials

Clinical Trials (4)

Research Network

Common Treatments

  • Azithromycin2
  • Video Education2
  • Azithromycin And Amoxicillin1

Active Sponsors

  • University of Alabama at Birmingham2
  • Institute of Nutrition of Central America and Panama1
  • University of North Carolina, Chapel Hill1
  • Lata Medical Research Foundation, Nagpur1
  • Merck Sharp & Dohme LLC1

Top Investigators

Related Conditions

  • Postpartum Hemorrhage2
  • Patient Empowerment2
  • Patient Education2
  • Postpartum Depression2
  • Postpartum Preeclampsia2

Activity Timeline